Martin Seidel is the founder of IFM Therapeutics. IFM Therapeutics has raised $56M in total funding. Backed by Omega Funds, Atlas Venture, Abingworth.
H. Martin Seidel is the Chief Executive Officer of IFM Therapeutics, a biopharmaceutical company focused on developing therapies for the innate immune system. He was appointed CEO in December 2019, transitioning from his role as Executive Vice President of Research and Development, which he joined full-time in 2017 after serving as a Board Observer since 2016. The company recently secured a $55.5 million financing round.
Full founder directory · Investor directory · Company funding database · Fundraising library